Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference

November 30, 2022

https://www.globenewswire.com/news-release/2022/11/30/2565369/0/en/Biofrontera-Inc-to-Participate-in-Benchmark-s-11th-Annual-Discovery-One-on-One-Investor-Conference.html

WOBURN, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq:BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the Company will be participating in Benchmark’s 11th Annual Discovery One-on-One Investor Conference being held on December 1, 2022 in New York, NY.

Read more at globenewswire.com

Related news for (BFRI)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.